首页> 外文期刊>Journal of Medicinal Chemistry >Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
【24h】

Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis

机译:叔胺吡唑啉酮及其盐作为突变型超氧化物歧化酶1依赖性蛋白聚集的抑制剂,用于治疗肌萎缩性侧索硬化症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pyrazolone derivatives have previously been found to be inhibitors of Cu/Zn superoxide dismutase 1 (S OD 1) - dep en dent protein aggregation, which extended survival of an amyotrophic lateral sclerosis (ALS) mouse model. On the basis of ADME analysis, we describe herein a new series of tertiary amine-containing pyrazolones and their structure activity relationships. Further conversion to the conjugate salts greatly improved their solubility. Phosphate compound 17 exhibited numerous benefits both to cellular activity and to CNS-related drug-like properties in vitro and in vivo, including microsomal stability, tolerated toxicity, and blood brain barrier permeation. These results indicate that tertiary amine pyrazolones comprise a valuable class of ALS drug candidates.
机译:吡唑啉酮衍生物先前已被发现是Cu / Zn超氧化物歧化酶1(S OD 1)-依赖蛋白质聚集的抑制剂,可延长肌萎缩性侧索硬化症(ALS)小鼠模型的生存期。基于ADME分析,我们在此描述了一系列新的含叔胺的吡唑啉酮及其结构活性关系。进一步转化为共轭盐可大大提高其溶解度。磷酸盐化合物17在体外和体内对细胞活性和与中枢神经系统相关的类药物特性均显示出众多益处,包括微粒体稳定性,耐受性毒性和血脑屏障渗透性。这些结果表明,叔胺吡唑啉酮包括有价值的一类ALS候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号